SCHEMBL31359071

SCHEMBL31359071

O=C(Cn1c(=O)[nH]c2ccccc2c1=O)NC(CO)c1ccc(F)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ KCNH2 Q12809 2/20 0.45
▸ HPGD P15428 5/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ HSP90AA1 P07900 1/20 0.44
▸ KDM4E B2RXH2 5/20 0.43
▸ TP53 P04637 1/20 0.43
▸ HSD17B10 Q99714 4/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ MAPK10 P53779 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MAPT P10636 2/20 0.42
▸ USP2 O75604 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ HTR2A P28223 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31359021 0.92 CYP1A2 (0.46) KMT2AMEN1KCNH2HPGDALDH1A1
SCHEMBL31358972 0.92 CYP1A2 (0.46) KMT2AMEN1KCNH2HPGDALDH1A1
SCHEMBL31358974 0.91 KMT2A (0.44) KMT2AMEN1KCNH2HPGDALDH1A1
SCHEMBL31359091 0.88 GPR139 (0.51) KMT2AMEN1KCNH2HPGDALDH1A1
SCHEMBL31160993 0.88 GPR139 (0.51) KMT2AMEN1KCNH2HPGDALDH1A1
SCHEMBL31359130 0.88 GPR139 (0.51) KMT2AMEN1KCNH2HPGDALDH1A1
SCHEMBL31358996 0.86 KMT2A (0.45) KMT2AMEN1KCNH2HPGDALDH1A1
SCHEMBL31358970 0.82 GPR139 (0.48) KMT2AMEN1KCNH2HPGDALDH1A1
SCHEMBL31359063 0.81 GPR139 (0.52) KMT2AMEN1KCNH2HPGDALDH1A1
SCHEMBL31359042 0.81 KMT2A (0.51) KMT2AMEN1KCNH2HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559464-B2 Quinazolinone dione compounds and uses thereof EDGEWISE THERAPEUTICS, INC. (US) 2026-02-24 — — US disclosed
US-20250026726-A1 QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. 2025-01-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026726-A1 QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF TNNI3, TNNT2, MYLK2 KMT2A 4427/4885MEN1 2683/4885KCNH2 387/4885
US-12559464-B2 Quinazolinone dione compounds and uses thereof TNNI3, TNNT2, TNNC1 KMT2A 4584/4885MEN1 3559/4885KCNH2 226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback